Universe Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Universe Pharmaceuticals INC (UPC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Sep 2023Sep 2022Sep 2021Sep 2020
Current Assets
Cash and Cash Equivalents33.5929.505.295.718.0810.06
Short-Term Investments0.000.0013.2213.1513.730.00
Cash & Short-Term Investments33.5929.505.2918.8621.8010.06
Accounts Receivable13.1917.8813.0015.1815.5710.87
Inventory2.191.743.342.212.461.91
Other Current Assets4.632.533.461.720.170.00
Total Current Assets53.6051.6425.2741.5150.4823.28
Non-Current Assets
Property, Plant & Equipment (Net)14.7015.343.7015.8317.874.43
Long-Term Investments0.700.710.690.700.740.74
Intangible Assets0.300.260.150.160.180.17
Other Non-Current Assets0.000.0011.3211.5813.190.00
Total Non-Current Assets15.7016.3216.4818.0319.660.00
Total Assets69.3067.9541.7259.5470.1428.80
Current Liabilities
Accounts Payable1.674.914.593.085.312.69
Short-Term Debt9.265.865.483.944.330.00
Current Portion of Long-Term Debt2.110.000.000.000.000.00
Accrued Liabilities0.851.233.022.540.440.94
Deferred Revenue0.040.000.000.000.000.00
Other Current Liabilities1.578.520.543.380.020.96
Total Current Liabilities13.1720.3113.7513.1011.218.00
Non-Current Liabilities
Long-Term Debt0.002.140.000.000.000.00
Other Non-Current Liabilities0.000.000.000.001.000.00
Total Non-Current Liabilities0.002.140.000.000.000.00
Total Liabilities13.1722.4513.7513.1011.218.00
Stockholders' Equity
Common Stock6.340.480.070.070.070.05
Retained Earnings-13.84-10.171.0016.3225.0616.18
Accumulated Other Comprehensive Income0.63-1.11-2.370.774.530.90
Additional Paid-in Capital63.0153.8629.2829.2829.280.00
Shares Outstanding0.560.040.010.010.010.00
Total Stockholders' Equity56.1345.5027.9746.4458.9320.80
Total Liabilities & Equity69.3067.9553.2959.5470.140.00